Found 443 matching trials
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus PHASE1 Post-transplant diabetes mellitus (PTDM) develops in up to 30% of patients ...
Show More Location
University of Colorado Denver
Learn More & Join Trial
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF) PHASE4 The evaluation of a standardized diagnostic test to predict the growth resp...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Japan. The aim of this trial is to investigate t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi PHASE4 Intensive insulin therapy using multiple daily injections (MDI) constitutes...
Show More Location
Institute for Clinical and Experimental Medicine
Learn More & Join Trial
Variation in Rate of Orthodontic Tooth Movement in Response to Platelet Rich Plasma Therapy PHASE4 PRP from 5 ml blood was prepared and 60 units were injected into the buccal...
Show More Learn More & Join Trial
Effects of Local Insulin on Varicose Ulcers for Wound Healing PHASE3 A randomized, split-plot, double-blind, placebo-controlled trial. The varic...
Show More Location
Mario Aurelio Martínez-Jiménez
Learn More & Join Trial
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in the United States of America (USA). The aim of t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy PHASE1 The study will be conducted in participants with type1 diabetes on insulin ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Learn More & Join Trial
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics PHASE1 This trial was conducted in Europe. The aim of this clinical trial was to e...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients PHASE2 This was a four month dose ranging study followed by a 24 to 48 month exten...
Show More Location
Anasazi Internal Medicine
Learn More & Join Trial